Triple antithrombotic therapy after coronary stenting in the elderly with atrial fibrillation: Necessary or too hazardous?

American Heart Journal

Volumn 163, Issue 4, 2012, Pages 531-534

  Verheugt, Freek W A ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

AGED; ANTICOAGULANT THERAPY; BLEEDING; CORONARY STENT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG FATALITY; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HUMAN; LOW DRUG DOSE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SOCIAL CLASS; STENT THROMBOSIS; THROMBOSIS;

EID: 84860197595     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.01.018     Document Type: Editorial

References (33)

1. C.W. Hamm, J.P. Bassand, and S. Agewall ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
2. J.P. Bassand, C.W. Hamm, and D. Ardissino Guidelines for the diagnosis and treatment of non ST-elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
3. C.U.R.E. Investigators Effect of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
4. D.L. Bhatt, K.A.A. Fox, and W. Hacke Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
5. ACTIVE Investigators Effect of clopidogrel added to aspirin in atrial fibrillation N Engl J Med 360 2009 1266 1278
6. F.W.A. Verheugt Good old warfarin for stroke prevention in atrial fibrillation Lancet 367 2006 1877 1878
7. K.A.A. Fox, S.R. Mehta, and R. Peters Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) trial Circulation 110 2004 1202 1208
8. J.W. Eikelboom, L. Wallentin, and S.J. Connolly Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial Circulation 123 2011 2363 2371
9. M.L. Hansen, R. Sørensen, and M.T. Clausen Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation Arch Intern Med 170 2010 1433 1441
10. E. Fosbol, T.Y. Wang, and S. Li Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction Am Heart J 163 2012 720 728
11. U. Stenestrand, J. Lindback, and L. Wallentin Anticoagulation in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from RIKS-HIA Circulation 112 2005 3225 3231
12. J.L. Orford, P. Fasseas, and S. Melby Safety and efficacy of aspirin, clopidogrel and warfarin after coronary stent placement in patients with an indication for anticoagulation Am Heart J 147 2004 463 467
13. M.C. Nguyen, Y.L. Li, and A. Walton Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Eur Heart J 28 2007 1717 1722
14. P.P. Karjalainen, P. Porela, and A. Ylitalo Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting Eur Heart J 28 2007 726 732
15. P.P. Karjalainen, S. Vikman, and M. Niemela Safety of percutaneous coronary intervention during uninterrupted oral anticoagulation Eur Heart J 29 2008 1001 1010
16. J.M. Ruiz-Nodar, F. Marin, and J.F. Hurtado Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation: implications for bleeding risk and prognosis J Am Coll Cardiol 51 2008 818 825
17. N. Sarafoff, G. Ndrepepa, and J. Mehilli Aspirin and clopidogrel with and without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation J Intern Med 264 2008 472 480
18. J.D. Douketis, P.B. Berger, and A.S. Dunn Perioperative management of antithrombotic therapy: American College of Chest Physician evidence-based clinical practice guidelines (8th edition) Chest 133 Supplement 6 2009 299S 339S
19. J.P. Collet, G. Montalescot, and B. Blanchet Impact of prior use of recent withdrawal of oral antiplatelet agents on acute coronary syndromes Circulation 110 2004 2361 2367
20. J.W. Van Werkum, A.A. Heestermans, and A.C. Zomer Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry J Am Coll Cardiol 53 2009 1399 1409
21. E. Ferrari, M. Benhamou, and P. Cerboni Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis J Am Coll Cardiol 45 2005 456 459
22. A.B. Maulaz, D.C. Bezerra, and P. Michel Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke Arch Neurol 62 2005 1217 1720
23. G.Y.H. Lip, K. Huber, and F. Andreotti European Society of Cardiology Working Group on Thrombosis. Antithrombotic management in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary stenting Eur Heart J 31 2010 1311 1318
24. D.P. Faxon, J.W. Eikelboom, and P.B. Berger Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North-American perspective: executive summary Circ Cardiovasc Interv 4 2011 522 534
25. S.J. Park, D.W. Park, and Y.H. Kim Duration of dual antiplatelet therapy after implantation of drug-eluting stents N Engl J Med 362 2010 1374 1382
26. W. Dewilde, and J.M. Ten Berg Design and rationale of the WOEST trial: what is the optimal antiplatelet and anticoagulant therapy in patients with oral anticoagulation and coronary stenting? Am Heart J 158 2009 713 718
27. A. Schömig, N. Sarafoff, and M. Seyfarth Triple antithrombotic management after stent implantation: when and how? Heart 95 2009 1280 1285
28. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
29. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
30. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
31. M.R. Patel, K.W. Mahaffey, and J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
32. C.B. Granger, J.H. Alexander, and J.J.V. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
33. A.L. Dans Concomitant use of antiplatelet therapy with dabigatran or warfarin (a sub-study from RE-LY) Presented European Congress of Cardiology, Paris, August 2011